Figure 2From: Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in TanzaniaIncremental cost-effectiveness scatter plot DhP versus AL. Key: The dots represent incremental cost-effect pairs for DhP versus AL for 10,000 Monte Carlo simulations. The dotted line represents a willingness-to-pay threshold of US$ 150 per DALY averted.Back to article page